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A B S T R A C T
Streptococcus pyogenes (Group A Streptococcus, GAS) infections can develop into life-threatening
disorders. However, the occurrence of some GAS pneumonia cases is relatively rare in a local community.
We report here characteristics of mucoid GAS isolates obtained from the sputum of two patients with
pneumonia in a local community. Although case-patients did not have contact with each other, case-
patient 10s child and case-patient 20s grandchild attended the same kindergarten where a GAS
pharyngitis epidemic had occurred. We conducted phenotypic and genotypic analyses with the GAS
isolates from sputum of both patients, to examine (1) colony appearance between the isolates, (2)
numerical proﬁle based on API-20 Strep system, (3) similarity to the type strain using 16S rRNA
sequencing, (4) emm type (subtype) and emm full-length sequence, (5) sequence type, (6) sic allele, (7)
antimicrobial susceptibility result and the resistance determinant, (8) genome proﬁle following a
random ampliﬁed polymorphic DNA fragments, and (9) pattern of digested DNA fragments by pulse-ﬁeld
gel electrophoresis. These phenotypic and genotypic analyses revealed similar matching between the
isolates from both cases. Our ﬁndings suggest that when clinicians examine adult patients having
infection with the mucoid GAS, they should conﬁrm whether anyone within the same household also
developed the infection and need to investigate epidemic situations in local communities, including
kindergartens and elementary schools.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Streptococcus pyogenes (Group A Streptococcus, GAS) infections
can develop into life-threatening disorders. GAS can be spread
from person to person via droplets or through contact with
infected wounds. Some reports describe nosocomial transmission
and spread among family members and nursing homes residents
[1,2]. But GAS pneumonia was relatively unusual in those settings.
Herein, we report our clinical experience with two temporally
proximal cases of pneumonia from whose sputum mucoid GAS
were isolated and phenotypic and genotypic analyses conducted* Corresponding author at: Department of General Internal Medicine, National
Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku,
Tokyo 152-8902, Japan.
E-mail address: noubaki.m@icloud.com (N. Mori).
http://dx.doi.org/10.1016/j.idcr.2016.09.002
2214-2509/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article unwith the GAS isolates to assess the potential epidemiological
relatedness.
Case 1
A 40-year-old woman presented to the emergency department
with fever, cough, diarrhea and vomiting 4 days prior to the
admission. The patient did not have a signiﬁcant past medical
history. Her children also had sore throat and fever 2 days before
the onset of her symptoms. On examination, her temperature was
39.6 C, blood pressure was 90/60 mmHg, pulse rate was 116 beats/
min, respiratory rate was 30 breaths/min, and oxygen saturation
was 95% (40% fraction of inspired oxygen, 9 L/min). Laboratory
tests showed leukocytosis (22,800/mL), elevated C-reactive protein
level (30.8 mg/dL), renal functional damage (creatinine: 1.93 mg/
dL), and disseminated intravascular coagulation, suggesting a toxic
shock syndrome. A chest X-ray and computed tomographyder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and bilateral pleural effusions. The patient was diagnosed with
severe pneumonia accompanied by septic shock and treated with
an intravenous antimicrobial combination of levoﬂoxacin (LVFX;
500 mg every 24 h) and ceftriaxone (CTRX; 2 g every 12 h), in
addition to recombinant human thrombomodulin. When the blood
and sputum cultures grew S. pyogenes, this regimen was simpliﬁed
to penicillin G (3 million units every 4 h) and clindamycin (600 mg
every 8 h). Since renal function was exacerbated and pleural
effusion increased, she also required hemodialysis and chest tube
placement. Her condition was subsequently complicated by a
drug-induced fever, skin eruption, and pneumonia. Therefore, the
combination changed just to CTRX (2 g every 24 h) on day 14 and
then to LVFX (500 mg every 24 h) on day 20. The patient completed
a course for 24 days and was then discharged.
Case 2
An 84-year-old woman was admitted after experiencing a
cough and dyspnea on exertion for 3 days. Although she had
mycosis fungoides, she was not taking medication for this disease.
Her grandchild had a sore throat several days before the onset of
her symptoms. Although the patient lived away from the
grandchild, she had contact with the grandchild preclinically.
The patient was taking medications for vertebral canal stenosis. In
addition to those, clarithromycin and carbocisteine were pre-
scribed for her respiratory symptoms by her primary care
physician on the day before admission. Her temperature was
37.3 C, blood pressure was 171/92 mmHg, pulse rate was 94 beats/Table 1
Phenotypic and genotypic characteristics and antimicrobial
from two patients.
M1 
Phenotypic and genotypic parameters
Clinical specimen Sputum
Gross appearance of colonies on sheep blood
agar plate
Mucoid
Numerical proﬁle using the API-20 Strep
system (% identiﬁcation)
0161417
Similarity (%) to S. pyogenes type straina using
16S rRNA sequencing (sequencing size, bp)
100 (14
emm type (subtype) 1(0.0) 
emm full-length (sequencing size, bp) Identica
MGAS5
Sequence type (allelic proﬁle: gki-gtr-murI-
mutS-recP-xpt-yqiL)
28 (43
Streptococcal inhibitor of complement (Sic)
allele No. (sequencing size, bp)
Sic1.32 
Antimicrobial agent resistance classb macroli
Macrolide resistance determinant mef(A) 
Antimicrobial agents Minimu
Penicillin G 0.03 
Ampicillin 0.06 
Cefepime 0.5 
Cefotaxime 0.12 
Ceftriaxone 0.12 
Meropenem 0.12 
Vancomycin 0.5 
Erythromycin >2 
Azithromycin >4 
Clindamycin 0.12 
Minocycline 1 
Levoﬂoxacin 1 
Chloramphenicol 4 
a S. pyogenes JCM 5674(T).
b Resistance to antimicrobials was determined by the bro
Laboratory Standards Institute document M100-S22.min, respiratory rate was 28 breaths/min, and oxygen saturation
was 90% at ambient air. Laboratory tests showed leukocytosis
(15,600/mL), an elevated C-reactive protein level (17.3 mg/dL), and
slightly elevated aminotransferases (aspartate transaminase: 45 U/
L; alanine transaminase: 38 U/L). A chest X-ray revealed pulmo-
nary inﬁltrate with air bronchogram in the right lower lobe. The
patient was diagnosed with community-acquired pneumonia and
treated with intravenous ampicillin/sulbactam (ABPC/SBT; 3 g
every 6 h). A sputum culture yielded S. pyogenes, but the blood
culture did not. She improved quickly and was then treated with
ABPC/SBT for 7 days.
These two cases occurred 2 weeks apart, and case-patient 10s
child and case-patient 20s grandchild had experienced self-limited
pharyngitis. Although the case-patients did not contact each other,
case-patient 10s child and case-patient 20s grandchild attended the
same kindergarten. Other children attending this kindergarten also
experienced pharyngitis within that time frame, suggesting an
epidemiological relationship of this GAS strain.
Microbiological analyses
To investigate the potential homology between the GAS isolates
(M1 and M2) from sputum cultures, we examined phenotypic and
genotypic characteristics. However, throat swabs specimens could
not be obtained from the remaining family members. Phenotypic
analyses examined colonial morphology on sheep blood agar plate,
the percent identiﬁcation by numerical proﬁle using the API-
20 Strep system (SYSMEX bioMérieux Co., Ltd., Tokyo, Japan), and
antimicrobial susceptibility data using the broth microdilution susceptibility results of Streptococcus pyogenes isolates
M2
 Sputum
 Mucoid
 (99.9) 0161417 (99.9)
18) 100 (1418)
1(0.0)
l to that of S. pyogenes
005 strain (1093)
Identical to that of S. pyogenes
MGAS5005 strain (1093)
-4-4-4-2-4) 28 (43-4-4-4-2-4)
(931) Sic1.32 (931)
de macrolide
mef(A)
m inhibitory concentration
0.03
0.06
0.5
0.12
0.12
0.12
0.5
>2
>4
0.12
1
1
4
th microdilution method according to the Clinical and
Fig. 2. Pulse-ﬁeld gel electrophoresis of SﬁI-digested DNA fragments from the same
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M1/M2 and the type strain using 16S rRNA gene sequencing [4],
determined the emm type (subtype), with the full-length
sequences [5], sequence type (ST) [6],sic allele [7], and macro-
lide/lincosamide (ML) resistance determinants including erm(A),
erm(B), and mef(A) [8]. Brieﬂy, all emm typing (sub-typing) was
based on the Centers for Disease Control and Prevention database
(http://www2a.cdc.gov/ncidod/biotech/strepblast.asp), and the
full-length sequencing was done with the same polymerase chain
reaction (PCR) primers. Multilocus sequence typing (MLST) to
obtain ST was performed by sequencing 7 housekeeping genes (gki,
gtr, murI, mutS, recP, xpt, and yqiL) according to the GAS pubMLST
website (http://pubmlst.org/spyogenes/). The sic gene was ampli-
ﬁed with primer pair (SIC.1/SIC.2), and we did the sequencing with
two sequencing primers SIC.3/SIC.4. The sic allele number was
determined and assigned by comparison to the reference allele.
The ML resistant gene was ampliﬁed by PCR, and was conﬁrmed by
the corresponding amplicon size on agarose gel electrophoresis.
We also performed genome proﬁling (GP) method based on
random PCR following a random ampliﬁed polymorphic DNA
fragments using a pfM12 primer with three GAS strains (ATCC
12344(T), M1, and M2) to clarify the genetic relatedness between
M1 and M2 [9]. Brieﬂy, we did (1) reproducible sampling of DNA
fragments from the original genomic DNA by random PCR, (2)
acquisition of the sequence-derived information without sequenc-
ing by using micro-temperature gradient gel electrophoresis, into
which random PCR products can be applied without puriﬁcation of
DNA fragments, and (3) normalization of the acquired data using
internal references. Pulse-ﬁeld gel electrophoresis (PFGE) of SﬁI-
digested DNA fragments with the same GAS strains [10] was also
carried out to conﬁrm difference in the patterns of DNA fragments
from the ATCC strain and clinical isolates.
Theses phenotypic and genotypic characteristics including
antimicrobial susceptibility results are shown in Table 1. Both
the GP-induced clustering image and the PFGE-induced patterns of
DNA fragments indicated similar, but not identical, clonality
between M1 and M2, but these strains were different from
ATCC12344 (Figs. 1 and 2). This similarity, but not identical,
clonality appears to be due to potential pathogen passage through
the local community.Fig. 1. Genome proﬁling based on random polymerase chain reaction using a pfM12 primer with three GAS strains (ATCC 12344(T), M1, and M2).
GAS strains (ATCC 12344(T), M1, and M2).
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Risk of GAS transmission from index cases to contacts depends
on the duration of exposure and the distance from the index case
[11]. According to data from the Tokyo Metropolitan Infectious
Disease Surveillance Center (survey.tokyo-eiken.go.jp/epidinfo/
zensu10bchart.do), the period in which the two patients had
GAS pneumonia did not occur during a GAS infection peak. GAS
isolates from the both patients most likely transmitted from the
classmates in the kindergarten who had been infected with
pharyngitis. Therefore, clinicians should also take a history
concerning epidemic information in the local community.
ST28, the same ST type as our isolates, is the most dominant
type in the MLST GAS database (http://pubmlst.org/spyogenes/)
and is also a major ST type in Japan in an epidemiological study of
erythromycin-resistant GAS [6]. In Japan, the incidence of invasive
GAS infections doubled from 2010 to 2012. The predominant
genotype was emm1 [12], the same as the isolates in this study. A
study using clinical isolates and mouse bone-marrow-derived
macrophages showed that the level of inﬂammatory mediators
produced was dependent on the emm type and emm1 type isolates
are able to induce the highest levels of pro-inﬂammatory cytokines
[13]. However, individuals infected with the same clone can
develop different clinical manifestations [14].
In our cases, case-patient 2 did not develop streptococcal toxic
shock syndrome, while case-patient 1 did, suggesting differences
in the disease manifestations due to emm1/ST28 or preexisting
superantigen antibody in the second patient. The roles of host
cellular mediators during GAS infection are poorly understood
[15]. Nevertheless, recent studies have shown that host leukocyte
receptor binding to GAS-derived products mediates the release of
inﬂammatory mediators associated with severe GAS disease. Kotb
et al. suggest that the variation in class II alleles/haplotypes can
inﬂuence invasive GAS infection outcomes indicating that host
factors may play an important role in the development of invasive
GAS infections [14]. We additionally considered that the difference
of disease course between both patients may result from the
frequency of contact with their child or grandchild and the length
from initial symptoms to visiting medical attention.
The sic gene encodes an extracellular protein known as
streptococcal inhibitor of complement secreted by serotype
M1 and M57 GAS. Changes in sic in during epidemics within a
population have been reported previously, but these events may
require prolonged carriage [7]. We suggest that changes in sic
between both patients were not identiﬁed, as both patients were
temporally proximal cases of GAS pneumonia.
The GAS strains isolated from our cases were mucoid. The
mucoid phenotype is due to increased production of capsular
polysaccharide including hyaluronate. A report investigating a
mucoid strain outbreak in Spain showed that invasive disease was
more often due to mucoid isolates than non-mucoid isolates (3% vs.
0.21%, p = 0.0001) [16]. Studies have emphasized the importance of
mucoid isolate detection in clinical practice. The isolation of
mucoid GAS colonies suggests an epidemic in the local community
and may help to prevent an outbreak of dangerous GAS infection in
local hospitals.
In summary, based on phenotypic and genotypic analyses, we
showed similar clonality of mucoid GAS isolates from two
temporally proximal cases of pneumonia. When examining adult
patients having infection with the mucoid GAS, clinicians should
conﬁrm whether anyone within the same household also
developed the infection. If any relatives have been affected,
clinicians also need to investigate epidemic situations in the
relatives’ communities, including kindergartens and elementary
schools.Conﬂict of interest statement
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